OncoCyte Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for OncoCyte stock have an average target of 4.42, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 60.73% from the current stock price of 2.75.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$4.42	$4.25	$5.00
Change	+45.45%	+60.73%	+54.55%	+81.82%

Analyst Ratings

The average analyst rating for OncoCyte stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mike Matson Needham	Needham	Strong Buy Reiterates $4.25	Strong Buy	Reiterates	$4.25	+54.55%	Nov 13, 2024
Mike Matson Needham	Needham	Strong Buy Reiterates $4.25	Strong Buy	Reiterates	$4.25	+54.55%	Oct 15, 2024
Mike Matson Needham	Needham	Strong Buy Reiterates $4.25	Strong Buy	Reiterates	$4.25	+54.55%	Aug 9, 2024
Mike Matson Needham	Needham	Strong Buy Reiterates $4.25	Strong Buy	Reiterates	$4.25	+54.55%	May 16, 2024
Mike Matson Needham	Needham	Strong Buy Maintains $3.6 → $4.25	Strong Buy	Maintains	$3.6 → $4.25	+54.55%	Apr 24, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

669.96K

from 1.50M

-55.42%

from 1.50M

Revenue Next Year

1.80M

from 669.96K

167.93%

from 669.96K

EPS This Year

-2.31

from -3.75

EPS Next Year

-1.75

from -2.31

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	1.22M	2.20M	958.00K	1.50M	669.96K	1.80M	7.17M
Revenue Growth	-	-	80.76%	-56.41%	56.89%	-55.42%	167.93%	299.50%
EPS	-8.74	-9.14	-14.42	-13.25	-3.75	-2.31	-1.75	-1.45
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	1.1M	2.3M	9.7M
Avg	669,963	1.8M	7.2M
Low	480,200	1.0M	4.9M

Revenue Growth

Revenue Growth	2024	2025	2026
High	-30.1%	244.8%	438.2%
Avg	-55.4%	167.9%	299.5%
Low	-68.1%	50.8%	173.0%

EPS Forecast

EPS	2024	2025	2026
High	-2.25	-1.62	-1.39
Avg	-2.31	-1.75	-1.45
Low	-2.38	-1.79	-1.51

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.